Nariman A Balenga1, William Jester2, Meiqi Jiang2, Reynold A Panettieri2, Kirk M Druey3. 1. Molecular Signal Transduction Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Md. 2. Pulmonary, Allergy and Critical Care Division, Airways Biology Initiative, University of Pennsylvania, Philadelphia, Pa. 3. Molecular Signal Transduction Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Md. Electronic address: kdruey@niaid.nih.gov.
Abstract
BACKGROUND: Although eosinophilic inflammation typifies allergic asthma, it is not a prerequisite for airway hyperresponsiveness (AHR), suggesting that underlying abnormalities in structural cells, such as airway smooth muscle (ASM), contribute to the asthmatic diathesis. Dysregulation of procontractile G protein-coupled receptor (GPCR) signaling in ASM could mediate enhanced contractility. OBJECTIVE: We explored the role of a regulator of procontractile GPCR signaling, regulator of G protein signaling 5 (RGS5), in unprovoked and allergen-induced AHR. METHODS: We evaluated GPCR-evoked Ca(2+) signaling, precision-cut lung slice (PCLS) contraction, and lung inflammation in naive and Aspergillus fumigatus-challenged wild-type and Rgs5(-/-) mice. We analyzed lung resistance and dynamic compliance in live anesthetized mice using invasive plethysmography. RESULTS: Loss of RGS5 promoted constitutive AHR because of enhanced GPCR-induced Ca(2+) mobilization in ASM. PCLSs from naive Rgs5(-/-) mice contracted maximally at baseline independently of allergen challenge. RGS5 deficiency had little effect on the parameters of allergic inflammation, including cell counts in bronchoalveolar lavage fluid, mucin production, ASM mass, and subepithelial collagen deposition. Unexpectedly, induced IL-13 and IL-33 levels were much lower in challenged lungs from Rgs5(-/-) mice relative to those seen in wild-type mice. CONCLUSION: Loss of RGS5 confers spontaneous AHR in mice in the absence of allergic inflammation. Because it is selectively expressed in ASM within the lung and does not promote inflammation, RGS5 might be a therapeutic target for asthma. Published by Mosby, Inc.
BACKGROUND: Although eosinophilic inflammation typifies allergic asthma, it is not a prerequisite for airway hyperresponsiveness (AHR), suggesting that underlying abnormalities in structural cells, such as airway smooth muscle (ASM), contribute to the asthmatic diathesis. Dysregulation of procontractile G protein-coupled receptor (GPCR) signaling in ASM could mediate enhanced contractility. OBJECTIVE: We explored the role of a regulator of procontractile GPCR signaling, regulator of G protein signaling 5 (RGS5), in unprovoked and allergen-induced AHR. METHODS: We evaluated GPCR-evoked Ca(2+) signaling, precision-cut lung slice (PCLS) contraction, and lung inflammation in naive and Aspergillus fumigatus-challenged wild-type and Rgs5(-/-) mice. We analyzed lung resistance and dynamic compliance in live anesthetized mice using invasive plethysmography. RESULTS: Loss of RGS5 promoted constitutive AHR because of enhanced GPCR-induced Ca(2+) mobilization in ASM. PCLSs from naive Rgs5(-/-) mice contracted maximally at baseline independently of allergen challenge. RGS5 deficiency had little effect on the parameters of allergic inflammation, including cell counts in bronchoalveolar lavage fluid, mucin production, ASM mass, and subepithelial collagen deposition. Unexpectedly, induced IL-13 and IL-33 levels were much lower in challenged lungs from Rgs5(-/-) mice relative to those seen in wild-type mice. CONCLUSION: Loss of RGS5 confers spontaneous AHR in mice in the absence of allergic inflammation. Because it is selectively expressed in ASM within the lung and does not promote inflammation, RGS5 might be a therapeutic target for asthma. Published by Mosby, Inc.
Entities:
Keywords:
Aspergillus fumigatus; Asthma; G proteins; airway hyperresponsiveness; regulator of G protein signaling proteins
Authors: Zhao Yang; Philip R Cooper; Gautam Damera; Indranil Mukhopadhyay; Hyeseon Cho; John H Kehrl; Reynold A Panettieri; Kirk M Druey Journal: J Biol Chem Date: 2011-01-29 Impact factor: 5.157
Authors: Laurent Benayoun; Anne Druilhe; Marie-Christine Dombret; Michel Aubier; Marina Pretolani Journal: Am J Respir Crit Care Med Date: 2003-01-16 Impact factor: 21.405
Authors: Joanne L Shaw; Samer Fakhri; Martin J Citardi; Paul C Porter; David B Corry; Farrah Kheradmand; Yong-Jun Liu; Amber Luong Journal: Am J Respir Crit Care Med Date: 2013-08-15 Impact factor: 21.405
Authors: Hongkuan Fan; Pengfei Li; Basilia Zingarelli; Keith Borg; Perry V Halushka; Lutz Birnbaumer; James A Cook Journal: Biochim Biophys Acta Date: 2011-01-19
Authors: Pengfei Li; Richard R Neubig; Basilia Zingarelli; Keith Borg; Perry V Halushka; James A Cook; Hongkuan Fan Journal: Inflammation Date: 2012-10 Impact factor: 4.092
Authors: Haihong Jiang; Yan Xie; Peter W Abel; Dennis W Wolff; Myron L Toews; Reynold A Panettieri; Thomas B Casale; Yaping Tu Journal: Am J Respir Cell Mol Biol Date: 2015-07 Impact factor: 6.914
Authors: Gordon S Wong; Jamie L Redes; Nariman Balenga; Morgan McCullough; Nathalie Fuentes; Ameya Gokhale; Cynthia Koziol-White; Joseph A Jude; Laura A Madigan; Eunice C Chan; William H Jester; Sabrina Biardel; Nicolas Flamand; Reynold A Panettieri; Kirk M Druey Journal: J Allergy Clin Immunol Date: 2020-03-19 Impact factor: 10.793
Authors: Nariman A Balenga; Michael Klichinsky; Zhihui Xie; Eunice C Chan; Ming Zhao; Joseph Jude; Michel Laviolette; Reynold A Panettieri; Kirk M Druey Journal: Nat Commun Date: 2015-04-13 Impact factor: 14.919